Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus
This study is ongoing, but not recruiting participants.
Study NCT01137695   Information provided by North Jersey Endocrine Consultants, LLC

First Received on June 3, 2010.   Last Updated on October 13, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 2 Diabetes Mellitus
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Pramlintide
Additional drug interventions recognized in this trial
Islet Amyloid Polypeptide
More general drug interventions related to this trial
Anti-Obesity Agents
Appetite Depressants
Central Nervous System Agents
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Cheryl Rosenfeld, DO
Amylin Pharmaceuticals, LLC.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services